Roy Vagelos
E26063
Roy Vagelos is an American physician, scientist, and former CEO of Merck & Co., renowned for his leadership in the pharmaceutical industry and major philanthropic support of medical education.
Aliases (2)
- P. Roy Vagelos ×4
- Vagelos ×1
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
business executive
→
human → philanthropist → physician → scientist → |
| academicDegree |
Bachelor's degree from the University of Pennsylvania
→
MD from Columbia University College of Physicians and Surgeons → |
| awardReceived |
Lasker-Koshland Special Achievement Award in Medical Science
→
National Medal of Science → |
| boardMemberOf |
Regeneron Pharmaceuticals
→
|
| countryOfCitizenship |
United States of America
→
|
| educatedAt |
Columbia University Vagelos College of Physicians and Surgeons
→
University of Pennsylvania → |
| employer |
Merck & Co.
→
|
| familyName |
Vagelos
→
|
| fieldOfWork |
biochemistry
→
pharmaceutical industry → pharmacology → |
| genreOfWork |
autobiographical and leadership writings in science and business
→
|
| givenName |
Pindaros
→
|
| hasHonor |
Vagelos College of Physicians and Surgeons named in his honor
→
Vagelos Life Sciences and Management Program at the University of Pennsylvania named in his honor → |
| hasInfluenced |
policies on corporate social responsibility in pharmaceuticals
→
|
| hasPhilanthropicFocus |
medical education
→
scientific research → undergraduate science education → |
| industry |
pharmaceutical industry
→
|
| knownFor |
global health initiatives at Merck & Co.
→
leadership in the pharmaceutical industry → major philanthropic support of medical education → |
| memberOf |
American Academy of Arts and Sciences
→
National Academy of Sciences → |
| name |
P. Roy Vagelos
→
|
| nativeLanguage |
English
→
|
| notableProject |
Merck Mectizan Donation Program
→
|
| notableWork |
Decision to provide ivermectin (Mectizan) free of charge for river blindness
→
Leadership of Merck & Co. in the 1980s and early 1990s → |
| occupation |
biochemist
→
chief executive officer → pharmaceutical executive → physician → |
| philanthropyTarget |
Columbia University Vagelos College of Physicians and Surgeons
→
University of Pennsylvania → |
| positionHeld |
Chairman of Merck & Co.
→
Chairman of the Board of Regeneron Pharmaceuticals → Chief Executive Officer of Merck & Co. → |
| residence |
New Jersey
→
|
| spouse |
Diana Vagelos
→
|
Referenced by (7)
| Subject (surface form when different) | Predicate |
|---|---|
|
Columbia University Vagelos College of Physicians and Surgeons
→
VP&S → |
namedAfter |
|
Roy Vagelos
("Vagelos")
→
|
familyName |
|
Diana Vagelos
("P. Roy Vagelos")
→
|
hasCollaborator |
|
Roy Vagelos
("P. Roy Vagelos")
→
|
name |
|
Diana Vagelos
("P. Roy Vagelos")
→
|
partnerInPhilanthropy |
|
Diana Vagelos
("P. Roy Vagelos")
→
|
spouse |